Skip to content

Comment on FDA clears blood test to aid evaluation for Alzheimer's diseaseparent

Comments

So we should just let companies flood doctors with potential treatments and then hope they have enough time to figure out whats relevant for their patients?

Seems much better use of time and money to have people developing tests meet a pre-defined standard and after that point they're allowed to flood doctors with marketing for the tests.

What use is future medical advancements if it can't meet low bars like proving it works?

The problem is the FDA's pathetic throughput times. It takes them decades to approve drugs. Blood tests take 1-2 years on average. It's a huge bottleneck. If they could turn these things around faster and work iteratively, it would be different.

October[1] to August[2] isn't even a single year.

Definitely longer than I'd expect for "cleared" considering everybody involved should have to be licensed and pretty sure you pay a fee to the FDA so that should cover the cost of FDA hiring employees to just call each person involved to verify the submission is accurate.

Although IIUC, they were already allowed to do 50yr+ people and the recent clearance is just for 40yr+ so I'm not actually sure how uh impactful this is (a bit more confused why it takes 10 months to drop the age by 10 years).

[1]: https://precivityad.com/news/c2n-submits-us-fda-regulatory-f...

[2]: https://c2n.com/news-releases/bg2ziqcz39o3wxf5uc04u279ziw0yv

AboutSource Built by g1lg1l

Hackerly is an independent reader for Hacker News, built on the public HN API. Not affiliated with Y Combinator.